Post-operative radiotherapy in non-small-cell lung cancer: more questions than answers
1996

Post-operative Radiotherapy in Non-Small-Cell Lung Cancer: More Questions Than Answers

Sample size: 154 Editorial Evidence: low

Author Information

Author(s): H Bartelink, J Jassem

Primary Institution: The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis

Hypothesis

The value of post-operative radiotherapy as an adjuvant to surgery for patients with non-small-cell lung cancer remains unproven.

Conclusion

The study indicates that while there is an improvement in local control, the trial lacks the statistical power to confirm a survival benefit.

Supporting Evidence

  • An improvement in time to local recurrence and distant metastases was observed in N2 patients.
  • Only 36% of patients allocated to radiotherapy received the treatment as specified in the protocol.
  • A larger trial is needed to adequately assess the effect of post-operative radiotherapy on survival.

Takeaway

Doctors are trying to find out if giving radiation after lung cancer surgery helps patients live longer, but they need more patients in their studies to be sure.

Methodology

The study involved a small randomized trial with a limited number of patients and low radiation doses.

Limitations

The trial had a small sample size, low radiation doses, many ineligible patients, inappropriate staging, and no quality assurance.

Participant Demographics

Patients with non-small-cell lung cancer, specifically N2 patients.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication